 |
|
Carbamazepine Increases Cerebrospinal Fluid Thyrotropin-Releasing Hormone Levels in Affectively Ill Patients
Lauren B. Marangell, MD;
Mark S. George, MD;
Garth Bissette, PhD;
Peggy Pazzaglia, MD;
Teresa Huggins, PhD;
Robert M. Post, MD
Arch Gen Psychiatry. 1994;51(8):625-628.
Abstract
Background
Thyrotropin-releasing hormone is an endogenous tripeptide with endocrine-independent neurophysiologic properties that may be relevant to affective or seizure disorders. We studied the effect of carbamazepine, which has both mood-stabilizing and anticonvulsant properties, on cerebrospinal fluid thyrotropin-releasing hormone levels in affectively ill patients.
Method
Paired cerebrospinal fluid samples were collected from nine inpatients with mood disorders, both while medication free and while taking carbamazepine for an average of longer than 1 month at 950 mg/d, achieving blood levels of 8.8 mg/L.
Results
Carbamazepine treatment was consistently and significantly associated with increased cerebrospinal fluid thyrotropin-releasing hormone levels (P<.0001).
Conclusion
As carbamazepine-induced increases in thyrotropin-releasing hormone levels could be relevant to either its psychotropic or anticonvulsant properties, further clinical and preclinical investigation of this finding appears indicated.
Author Affiliations
From the Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, Md (Drs Marangell, George, Pazzaglia, Huggins, and Post); and Department of Psychiatry, Duke University Medical Center, Durham, NC (Dr Bissette). Dr Marangell is now with the Department of Psychiatry, Baylor College of Medicine, Houston, Tex.
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Effects of Intrathecal Thyrotropin-Releasing Hormone (Protirelin) in Refractory Depressed Patients
Marangell et al.
Arch Gen Psychiatry 1997;54:214-222.
ABSTRACT
|
